CIK 0001671502 · Non-accelerated filer<br>Smaller reporting company
Quoin Pharmaceuticals Ltd.
Sign in to watch- Ticker
- QNRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 703 980 4182
- Business address
- 42127 PLEASANT FOREST COURT, ASHBURN, VA, 20148-7349
- Former names
- Quoin Pharmaceuticals, Ltd., Cellect Biotechnology Ltd., Cellect Biomed Ltd.
- 8-K Event Other events
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Other events
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Other events
- SCHEDULE 13D Stake Beneficial Ownership Report
- SCHEDULE 13D Stake Beneficial Ownership Report
- 4 Open-market buy Chief Operating Officer bought 555,556 shares at $0.45 ($250,000)
- 4 Open-market buy Chief Executive Officer bought 555,556 shares at $0.45 ($250,000)
- 4 Open-market buy Chief Financial Officer bought 122,221 shares at $0.45 ($54,999)
- 4 Open-market buy Director bought 100,000 shares at $0.45 ($45,000)
- 8-K Event Material agreement · Other events
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 8-K Event Other events
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 7 of 30 · 585 filings